China Targets Big Pharma

China unveiled a litany of bribery and misconduct allegations against GlaxoSmithKline, a move that industry experts said could presage a broader crackdown in a lucrative market for pharmaceutical and medical companies.

Speak Your Mind

Subscribe to get this amazing EBOOK FREE

Real Estate 101 - Buying Your First Home!

By subscribing to this newsletter you agree to our Privacy Policy